Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents
Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents
BGB-A317-301 JapicCTI-194569
Active, not recruiting
Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCC
Beigene Study ID
BGB-A317-301 JapicCTI-194569
ClinicalTrials.gov ID
EudraCT Number
2017-002423-19
Clinical Drug Trials ID
CTR20170882
Sex: All
Age: 18 Years and older (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents
Sex: All
Age: 18 Years and older (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents